GlassScriptPhysician profile
Mahmoud Alameddine
NPI 1730595778
$25,550.99
in general payments reported to CMS, 2019-2025
25 companies · $621 in 2025
The $621 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,930 · 2020: $330 · 2021: $1,546 · 2022: $1,868 · 2023: $11K · 2024: $5,109 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Food and Beverage: $1,741 · Travel and Lodging: $1,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,846.02 |
| Food and Beverage | $1,740.69 |
| Travel and Lodging | $1,290.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,342.88 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Coloplast Corp | $2,085.56 | 2019-2022 | |
| Teleflex LLC | $1,987.01 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $1,761.22 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $1,137.79 | 2019-2025 | Xtandi |
| Boston Scientific Corporation | $1,107.67 | 2019-2023 | Spaceoar Vue System - 10ml |
| Pfizer INC. | $671.77 | 2019-2025 | |
| Urovant Sciences INC | $197.12 | 2021-2022 | |
| Tolmar, INC. | $185.52 | 2023-2025 | Jatenzo, Eligard |
| Sumitomo Pharma America, INC. | $149.91 | 2023-2025 | Gemtesa |
| Tolmar Pharmaceuticals, INC. | $142.04 | 2020-2022 | |
| Janssen Biotech, INC. | $137.90 | 2022-2025 | Erleada |
| 180 Medical, INC. | $103.03 | 2023-2025 | Gentlecath, Gentlecath Glide |
| Axonics, INC. | $100.67 | 2022-2024 | Axonics |
| Urogen Pharma, INC. | $83.03 | 2024-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $82.26 | 2022-2025 | Interstim |
| Healthtronics Stone Solutions, LLC | $56.13 | 2022-2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Allergan, INC. | $51.12 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.55 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Medline Industries LP | $28.23 | 2022-2023 | |
| Vertex Pharmaceuticals Incorporated | $20.64 | 2025 | |
| Photocure INC | $15.09 | 2022 | |
| Abbvie INC. | $15.05 | 2025 | |
| Myovant Sciences INC. | $14.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahmoud Alameddine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.